Results 31 to 40 of about 195,106 (347)

First-emerging islet autoantibody and glucose metabolism: search for type 1 diabetes subtypes

open access: yesEndocrine Connections, 2022
Objective: Subtypes in type 1 diabetes pathogenesis have been implicated based on the first-appearing autoantibody (primary autoantibody). We set out to describe the glucose metabolism in preclinical diabetes in relation to the primary autoantibody in ...
Olli Helminen   +6 more
doaj   +1 more source

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

open access: yesFrontiers in Immunology, 2020
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by autoantibodies targeting neuromuscular junction proteins.
K. Lazaridis, S. Tzartos
semanticscholar   +1 more source

Autoantibody Testing in Neuromuscular Disorders [PDF]

open access: yes, 2022
Autoantibodies are present in many autoimmune disorders, including diseases impacting the peripheral nerve, neuromuscular junction, and muscle. Some of these autoantibodies play a vital role in pathogenesis, whereas others are unlikely to be directly ...
김승우, 신하영
core   +1 more source

Lymphocytotoxic Autoantibodies [PDF]

open access: yes, 2007
Anti-lymphocytic antibodies (anti-LCA) are detected in patients with systemic lupus erythematosus (SLE) with a prevalence ranging from 60–90%. LCA detection is associated with nephritis and neurologic disorders in these patients, and high rates of LCA occur during phases of active SLE.
Renaudineau, Yves   +2 more
openaire   +2 more sources

Autoantibody Signature in Cardiac Arrest [PDF]

open access: yes, 2020
Background: Cardiac arrest is a tragic event that causes one death roughly every 90 seconds worldwide. Survivors generally undergo a work-up to identify the etiology of arrest. However, 5- 10% of cardiac arrest remain unexplained.
Ribi, Camillo   +14 more
core   +2 more sources

Advanced Autoantibody Testing in Systemic Sclerosis [PDF]

open access: yes, 2023
Systemic sclerosis is a systemic autoimmune rheumatic disease characterized by immune abnormalities, leading to vasculopathy and fibrosis. Autoantibody testing has become an increasingly important part of diagnosis and prognostication.
Almaabdi, Kholoud   +5 more
core   +1 more source

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity

open access: yesRheumatology, 2020
Objectives In order to address the reliability of commercial assays to identify myositis-specific and -associated autoantibodies, we aimed to compare the results of two commercial immunoassays with the results obtained by protein immunoprecipitation ...
S. Tansley   +3 more
semanticscholar   +1 more source

Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations.

open access: yesPLoS ONE, 2021
BackgroundNo medical treatment has proven efficacy for acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF), and this syndrome has a very high mortality.
Tejaswini Kulkarni   +10 more
doaj   +1 more source

Use of two methods to elute anti-IgG and anti-(IgG + C3d) type autoantibody from sensitized erythrocytes

open access: yesGlobal Journal of Transfusion Medicine, 2018
Background: Autoimmune hemolytic anemia (AIHA) is an immunological disease caused by autoantibodies. Warm autoantibody mainly includes anti-IgG and anti-(IgG+C3d) type, which can cause direct antiglobulin test (DAT) positive.
He Ziyi, Hu Yingming, Cui Siping
doaj   +1 more source

Detection of Desmoglein-3 Auto-Antibodies in Patients with Lichen Planus [PDF]

open access: yesEgyptian Journal of Medical Research, 2022
There is controversy about the role of auto anti-bodies against desmoglein 3 (Dsg 3) in the pathogenesis of lichen planus (LP). The goal of this study is to detect desmoglein-3 auto-antibodies in lichen planus patients comparted to normal control persons
Abd-El Aziz El-Rifaie   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy